Stifel: Now's The Time To Buy These 3 Stocks

Loading...
Loading...

In a recent report, Stifel analysts gave their bullish analysis of several stocks. Here’s a breakdown of what the analysts had to say about three of their Buy-rated names.

Jazz Pharmaceuticals plc JAZZ

Analysts see “blockbuster potential” for Jazz’s defibrotide drug that Jazz acquired full rights to in 2014. The drug, used to treat hepatic veno-occlusive disease, has already launched in Europe and is working its way down the U.S. regulatory pathway.

Analysts believe that that defibrotide will see expanded uses in the future and that the drug could eventually surpass the value of Jazz’s flagship drug, Xyrem.

Related Link: EXCLUSIVE: LoopPay CEO Talks Samsung Acquisition

Analysts feel that the market is not fully appreciating the potential of defibrotide, and they name Jazz as a top pick and place a $225.00 target on the stock.

Norwegian Cruise Line Holdings Ltd NCLH

The major case analysts make for Norwegian Cruise Line is a valuation case. Analysts note that the stock currently trades at just about 12x their 2016 earnings per share estimates for the company. Stifel is predicting 20 percent earnings growth for the company in each of the next three years.

Norwegian Cruise's stock jumped by more than 7 percent on Wednesday after Tuesday’s earnings beat, and Stifel sees more even more upside to come.

The firm has a Buy rating on the stock and a $49.00 price target.

WellCare Health Plans, Inc. WCG

After a shaky past that includes wild swings in share price, an FBI raid and other drama, Stifel analysts are convinced that WellCare finally has a management team that understands the importance of both executing the company’s business plan and communicating clearly with shareholders.

Analysts predict that WellCare’s revenue and earnings will double in the next few years.

Stifel currently has a Buy rating on WellCare and a $100.00 price target on the stock.

Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorLong IdeasPrice TargetReiterationAnalyst RatingsTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...